Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Vanguard Windsor Investor Shares

Pzena Large Cap Value

Fiduciary Mgt of Milwaukee Lg-Cap Eq

1832 AM U.S. Low Volatility Equity LP I

Pzena Large Cap Focused Value

Pzena Mid Cap Value Instl

MD American Value

Fidelity Series Global ex US Index

Pzena US Large Cap Value Fund A Acc USD

Pzena Large Cap Value Clear

ActivePassive International Equity ETF

PMC Diversified Equity

Dodge & Cox Balanced Composite

Dodge & Cox Balanced I

Vanguard Selected Value Inv

Pzena Mid Cap Value

JHancock Classic Value A

FMI Large Cap Investor

Liberty All-Star Equity

MDPIM US Equity Pool

Pzena Investment Management, LLC

Fiduciary Management, Inc. of Milwaukee

Moran Wealth Management LLC

VisionPoint Advisory Group, LLC

Two Sigma Investments LLC

Quantinno Capital Management LP

Geode Capital Management, LLC

Jane Street Group LLC

CI Private Wealth LLC

FMR Inc

Franklin Resources Inc

Nuveen Asset Management, LLC

Dodge & Cox

Morgan Stanley - Brokerage Accounts

Goldman Sachs Group Inc

BlackRock Inc

Integral Health Asset Management, LLC

Envestnet Asset Management Inc

Arrowstreet Capital Limited Partnership

Northern Trust Corp

Fresenius Medical Care Corporation

Ms. Helen  Giza

Chair of Management Board & CEO

Mr. Martin  Fischer

CFO & Member of the Management Board

Dr. Franklin W. Maddux F.A.C.P.

Global Chief Medical Officer & Member of Management Board

Dr. Katarzyna  Mazur-Hofsab Ph.D.

CEO of Care Enablement & Member of Management Board

Mr. Craig  Cordola FACHE, M.B.A., M.H.A.

CEO of Care Delivery & Member of Management Board

Dr. Dominik  Heger

Executive VP and Head of Investor Relations, Strategic Development & Communications

FMS's next earnings is on February 25, 2025 (Before Market Open)

FMS's latest dividend is 0.64284 USD on May 17, 2024

Fresenius Medical Care Corporation (FMS) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Fresenius Medical Care Corporation (FMS) Earnings Report Date and History | NYSE

FMS's next earnings is on February 25, 2025 (Before Market Open)

When is the earnings report for FMS?

FMS Earnings History

FMS's latest dividend is 0.64284 USD on May 17, 2024

FMS Stock Discussion Forum and Message Board

News for NYSE: FMS